WO2007071861A8 - Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations - Google Patents

Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations

Info

Publication number
WO2007071861A8
WO2007071861A8 PCT/FR2006/051243 FR2006051243W WO2007071861A8 WO 2007071861 A8 WO2007071861 A8 WO 2007071861A8 FR 2006051243 W FR2006051243 W FR 2006051243W WO 2007071861 A8 WO2007071861 A8 WO 2007071861A8
Authority
WO
WIPO (PCT)
Prior art keywords
compound
salts
irritant
compositions including
retinoid
Prior art date
Application number
PCT/FR2006/051243
Other languages
English (en)
Other versions
WO2007071861A2 (fr
WO2007071861A3 (fr
Inventor
Laurent Fredon
Claire Mallard
Eve Ferrara
Original Assignee
Galderma Res & Dev
Laurent Fredon
Claire Mallard
Eve Ferrara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev, Laurent Fredon, Claire Mallard, Eve Ferrara filed Critical Galderma Res & Dev
Priority to EP06842054A priority Critical patent/EP1965872A2/fr
Priority to CA002632911A priority patent/CA2632911A1/fr
Publication of WO2007071861A2 publication Critical patent/WO2007071861A2/fr
Publication of WO2007071861A3 publication Critical patent/WO2007071861A3/fr
Priority to US12/213,154 priority patent/US20090098219A1/en
Publication of WO2007071861A8 publication Critical patent/WO2007071861A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne une composition pour application topique comprenant, dans un milieu physiologiquement acceptable, au moins un composé rétinoïde choisi parmi l'acide rétinoîque tout trans, l ' isotrétinoïne, le notrétinide et les dérivés d'acide naphtoique de formule (I), leurs sels et esters : et au moins un composé anti-irritant choisi parmi l 'allantoïne, l'EDTA, les sels divalents de strontium, les sels divalents de zinc, les sels monovalents de sodium, et leurs dérivés hydratés.
PCT/FR2006/051243 2005-12-15 2006-11-28 Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations WO2007071861A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP06842054A EP1965872A2 (fr) 2005-12-15 2006-11-28 Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations
CA002632911A CA2632911A1 (fr) 2005-12-15 2006-11-28 Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations
US12/213,154 US20090098219A1 (en) 2005-12-15 2008-06-16 Cosmetic/pharmaceutical compositions comprising retinoids and anti-irritants and treatment of keratinization disorders therewith

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0512759 2005-12-15
FR0512759A FR2894820B1 (fr) 2005-12-15 2005-12-15 Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations

Publications (3)

Publication Number Publication Date
WO2007071861A2 WO2007071861A2 (fr) 2007-06-28
WO2007071861A3 WO2007071861A3 (fr) 2007-10-04
WO2007071861A8 true WO2007071861A8 (fr) 2008-09-04

Family

ID=36940257

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2006/051243 WO2007071861A2 (fr) 2005-12-15 2006-11-28 Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations

Country Status (5)

Country Link
US (1) US20090098219A1 (fr)
EP (1) EP1965872A2 (fr)
CA (1) CA2632911A1 (fr)
FR (1) FR2894820B1 (fr)
WO (1) WO2007071861A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140135372A1 (en) 2010-02-02 2014-05-15 Elliott Farber Compositions and methods of treatment of inflammatory skin conditions using allantoin
EP2854793B1 (fr) 2012-06-01 2021-10-27 Galderma Research & Development Nanocapsules lipidiques comprenant un rétinoide, nanodispersion et composition les contenant, leur procédé de préparation et leur utilisation en dermatologie
FR2991174B1 (fr) 2012-06-01 2014-12-26 Galderma Res & Dev Composition dermatologique comprenant des oleosomes et des retinoides, son procede de preparation et son utilisation
CN103099775B (zh) * 2012-10-08 2014-12-31 天津金耀集团有限公司 阿达帕林凝胶
WO2015100348A1 (fr) * 2013-12-27 2015-07-02 Scioderm, Inc. Réduction des chéloïdes au moyen d'allantoïne topique
JP7299766B2 (ja) * 2018-06-16 2023-06-28 ロート製薬株式会社 外用組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804203A (en) * 1994-12-21 1998-09-08 Cosmederm Technologies Topical product formulations containing strontium for reducing skin irritation
US6048902A (en) * 1999-02-12 2000-04-11 Lebwohl; Mark G. Short contact treatment of psoriasis with topical retinoids
US7268148B2 (en) * 1999-05-20 2007-09-11 Regents Of The University Of Michigan Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
GB9913408D0 (en) * 1999-06-10 1999-08-11 Albright & Wilson Uk Ltd Personal care formulations
US6583184B1 (en) * 2000-11-27 2003-06-24 Avon Products, Inc. Compositions having comfrey and methods for reducing retinoid-induced skin irritation
US6551605B2 (en) * 2001-04-06 2003-04-22 Haarmann & Reimer Diesters or polyesters of naphthalene dicarboxylic acid as solubilizer/stabilizer for retinoids
AU2003270272B2 (en) * 2002-09-05 2008-06-19 Galderma Research & Development, S.N.C. Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent
FR2871377B1 (fr) * 2004-06-11 2007-08-24 Galderma Res & Dev Gel depigmentant hydroalcoolique comprenant du mequinol et de l'adapalene
US20060128808A1 (en) * 2004-10-20 2006-06-15 Galderma Research & Development, S.N.C. Method of using adapalene in acne maintenance therapy
FR2916966B1 (fr) * 2007-06-11 2011-01-14 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations

Also Published As

Publication number Publication date
EP1965872A2 (fr) 2008-09-10
WO2007071861A2 (fr) 2007-06-28
CA2632911A1 (fr) 2007-06-28
US20090098219A1 (en) 2009-04-16
FR2894820B1 (fr) 2008-02-29
WO2007071861A3 (fr) 2007-10-04
FR2894820A1 (fr) 2007-06-22

Similar Documents

Publication Publication Date Title
WO2007071861A8 (fr) Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations
MY151295A (en) Pyrimidyl indoline compound
TW200744588A (en) Pharmaceutical composition for external use
WO2007015004A3 (fr) Nouvelle forme cristalline v de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
RS53292B (en) CRYSTAL FORMS 2-THIAZOLYL-4-HINOLINYL-OXY DERIVATIVES, POWERFUL HCV INHIBITOR
RS52716B (en) HYDROBENZAMIDE DERIVATIVES AS HEAT SHOCK PROTEIN INHIBITORS HSP90
AU2008255733A8 (en) Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity
WO2007015002A3 (fr) Nouvelle forme cristalline iv de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
MX363983B (es) Compuestos de enaminocarbonilo sustituidos.
RS51954B (en) CRYSTAL MODIFICATIONS OF PYRACLOSTROBIN
MX2009003823A (es) Nueva difenilazetidinona sustituida con acido piperazina-1-sulfonico y que tiene propiedades farmacologicas mejoradas.
RS54485B1 (en) C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS
UA100841C2 (en) Normal;heading 1;heading 2;heading 3;STABLE VITAMIN C COMPOSITIONS
AU2009258040A8 (en) Compounds and method for reducing uric acid
WO2007109578A3 (fr) Gamma lactames substitues en tant qu'agents therapeutiques
MY147188A (en) Substituted imidazole compounds as ksp inhibitors
AU2008258588A8 (en) Anti -inflammatory substituted cyclobutenedione compounds
WO2009153461A3 (fr) Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
NZ591814A (en) Pesticidal composition comprising an alpha-alkoxyphenyl acetic acid derivative and a neonicotinoid compound
RS54146B1 (en) CIKLOPENTILAKRILAMIDA DERIVATIVES
WO2007099548A3 (fr) Nouvelles 11 beta - hydroxyandrosta-4-ene-3-ones
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
GEP20146152B (en) Compositions of triazole
WO2010100470A3 (fr) Améliorations apportées et liées à des compositions biocides
MX2010002196A (es) Composicion radiofarmaceutica.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006842054

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2632911

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2006842054

Country of ref document: EP